Intuitive Surgical Stock - Friday sector check on a quiet news day
19.06.2026 - 19:32:41 | ad-hoc-news.de
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 17:30 CET. Details in the imprint.
Intuitive Surgical (US46120E6023) remains a key name in robotic surgery as the week closes without fresh company announcements or major filings. With no new headlines from its investor relations page or leading wire services on Friday, attention shifts to the stock’s sector backdrop and weekly performance.
All news and data on Intuitive Surgical stock
Track the latest headlines, quote data and filings on Intuitive Surgical stock in one place via our dedicated topic page and the company’s investor relations hub.
What Reuters and IR pages show
A review of Intuitive Surgical’s investor relations site on Friday afternoon showed no new press releases, earnings updates, or major regulatory filings over the previous 24 hours, and major wires such as Reuters also carried no fresh company-specific headlines in that window.
This muted news flow follows the company’s regular pattern outside earnings season, where trading is often driven more by sector moves, macro data and analyst positioning than by stock-specific announcements.
Weekly performance and sector backdrop
Recent quote data indicate Intuitive Surgical shares last closed on Nasdaq at about $406.78 on 06/18/2026, implying a market capitalization around $144 billion and a trailing price-to-earnings ratio near 49.
This level keeps the stock firmly in large-cap medical technology territory, alongside other equipment makers, even as the wider medtech group has faced mixed sentiment amid debates over procedure volumes and hospital capital budgets.
How Intuitive compares with medtech peers
Against a peer set of medical instruments and equipment names, Intuitive’s valuation remains at the higher end, which reflects its strong franchise in robotic-assisted surgery but also leaves the shares sensitive to any signs of slower system placements or lower procedure growth.
Many diversified medtech peers trade on lower earnings multiples, but they often have broader product portfolios beyond surgical robotics, while Intuitive’s concentration gives it clearer exposure to trends in minimally invasive procedures and hospital investment cycles.
The product behind the stock
Intuitive Surgical generates most of its revenue from the da Vinci Surgical System and related instruments and services, supplying hospitals with robotic platforms that enable minimally invasive procedures across urology, gynecology, general surgery and other specialties.
Where the stock trades today
The shares of Intuitive Surgical (US46120E6023) last traded on Nasdaq at $406.78 as of 06/18/2026, 22:00 CET, based on delayed quote data in USD.
Key facts on Intuitive Surgical stock
- Company: Intuitive Surgical Inc.
- ISIN: US46120E6023
- WKN: 888024
- Ticker: ISRG
- Venue: Nasdaq
- Price (as of 06/18/2026, 22:00 CET): 406.78 USD
- Market cap: 144,000,000,000 USD (as of 06/18/2026)
- Sector / Industry: Health Care / Medical Technology
- Index membership: Standard & Poor's 500 index, Nasdaq-100
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
